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TECHNICAL NOTE
Thromboxane synthase expression co-localizes with infiltrating
macrophages in renal allograft biopsies
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and ELEANOR L. Ros3
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Laboratory Medicine Service, VA Medical Center, Gainesville, Florida, USA
Thromboxane synthase (TS) catalyzes the formation of the
eicosanoid thromboxane (TxA2), which is a potent vasoconstrictor
and activator of platelet aggregation. It has a widespread distri-
bution, including hemopoietic cells (platelets, macrophages,
monocytes) and many tissues, such as lung, liver, kidney, and
spleen [11. Cultured renal cells including mesangial cells, tubular
epithelia, and medullary interstitial cells have also been found to
produce TxA2 [21. TxA2 has been proposed as a potential
mediator of cyclosporine nephrotoxicity in renal allografts. In this
light, the TS inhibitor, CGS 13080, has been used to attenuate the
decrease in renal function caused by cyclosporine, but with mixed
results [4, 5]. In human renal allografts undergoing acute or
chronic rejection, we found thromboxane synthase expression in
cells which appear to be infiltrating macrophages or monocytes by
morphology [3]. This study describes an immunohistochemical
technique utilized to confirm whether parenchymal renal cells or
macrophages account for this TS enzyme expression. This method
is based in histochemical double-labeling technique utilizing the
immunoperoxidase avidin/biotin system and two monoclonal an-
tibodies: Kon 7 and KP1. Kon 7 is a mouse monoclonal antibody
directed against TS [2]. KP1 is a mouse anti-human monoclonal
antibody directed against the CD68 antigen present in a lysosomal
fraction of human lung macrophages and identifies macrophages
and other phagocytic mononuclear cells [6].
Methods
Fourteen biopsy specimens from 14 renal allograft recipients
who underwent a percutaneous renal allograft biopsy from Janu-
ary 1994 to June 1994 were used for this study. Indications for the
biopsy include: rising serum creatinine or delayed graft function.
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Biopsies were obtained under ultrasonographic guidance using a
modified Vim-Silverman needle or an automated biopsy gun. The
tissues were fixed in a proprietary buffered formaldehyde ionized
zinc solution (Z-fix, Anatech Ltd., Battle Creek, MI), embedded
in paraffin wax, and processed for routine histological studies
including hematoxylin-eosin and periodic acid-Schiff stains. The
histopathologic diagnoses in this collection of 14 specimens
include: acute rejection (5), chronic rejection (3), acute and
chronic rejection (2), acute tubular necrosis (2), recurrent mem-
branoproliferative glomerulonephritis type I (1), and recurrent
diabetes (1).
In preparation for labeling with the first primary antibody, the
tissue sections were first deparaffinated in xylene and washed with
100% ethanol, 95% ethanol, and 70% ethanol, followed by
distilled water. Endogenous peroxidase activity was blocked with
0.3% H202 in methanol, followed by standard phosphate buffered
saline (PBS) washes (10 m Na P04, pH 7.5, 0.9% NaC1). The
tissues were then blocked with 5% normal serum solution (NSS)
from the Vectastain ABC/DAB Elite kit (mouse IgG type,
Burlingame, CA). Excess serum was blotted, followed by a 30
minute incubation with the TS antibody, Kon 7 (courtesy of Dr.
Volker Ulirich, Universitat Konstanz, Konstanz, Germany) at a
dilution of 1:1000 in 5% NSS. The tissues were washed in PBS,
and incubated with biotinylated secondary horse anti-mouse IgG
antibody (Vectastain ABC/DAB Elite kit). After washing with
PBS, ABC Reagent (Vectastain ABC/DAB Elite kit) followed by
diaminobenzidine hydrotetrachloride (DAB) chromagen (brown
color) were sequentially added, and finally washed with PBS.
In preparation for labeling these same tissue specimens with the
secondary primary antibody, KP1, tissues were blocked with 5%
NSS/PBS. KP1 was then applied at a 1:6 dilution in 5% NSS for 30
minutes, followed by a PBS wash. Secondary antibody (horse
anti-mouse IgG) was again applied, followed by PBS wash, 5
minutes, 2 changes. ABC reagent was applied, followed by a PBS
wash, and a second chromogen, Vector SG (blue color, Vector SG
kit, Burlingame, CA) was applied, incubated, and rinsed with
distilled water.
The tissue specimens were not counterstained with hematoxy-
lin, since the counterstain can interfere with the chromogen color.
They were mounted and coverslipped using Crystalmount me-
dium.
Fourteen biopsies were double-labeled, while four of the four-
teen were single-labeled with either Kon-7 or KP-1 and stained
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Fig. 1. Low magnification view of cortex with glomerulus (left), tubules Fig. 2. Intennediate magnification of tubules and vein with interstitial
(center) and vascular plexus (arteriole and vein right center) showing inflammation. [Stain Kon 7/DAB (brown) and KP1/Vector SG (blue);
inflammatoiy cell infiltrate. The inflammation is present in glomeruli and Magnification 412X].
around tubules and vessels [Stain Kon 7/DAB (brown) and KP1/Vector
SG (blue); Magnification 210x].
Fig. 3. Biopsy specimen double-stained with Kon 7/DAB (brown) followed Fig. 4. Biopsy specimen single-stained with Kon 7/DAB (brown) and hema-
by KPJ/Vector SG (blue). Interstitial cells show staining with both brown toxylin nuclear counterstain (blue). Interstitial cells show staining with the
and blue chromogens. (Magnification x 1020). brown chroinogen. (Magnification X 1020).
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with Vector SG (blue color) or DAB (brown color) to determine
baseline staining and quality. Negative controls consisted of the
above protocol without the application of either antibody. Normal
renal tissue samples were also processed under the same condi-
tions as the biopsy specimens as additional negative tissue con-
trols.
Results
All of the biopsy specimens showed specific light blue or dark
brown single- or double-antibody staining within the cytoplasm of
cells found in the interstitium or glomerulus. The biopsy speci-
mens which underwent the double-labeling procedure demon-
strated numerous interstitial cells which stained dark brown for
thromboxane synthase (Kon 7 positive, brown color) (Fig. 1).
Under high magnification (Figs. 2, 3), cells appearing to stain for
the TS antibody also showed blue granules, due to the staining of
the macrophage marker (KP1, positive blue color). Therefore, all
cells expressing thromboxane synthase (Kon 7, DAB chromogen,
brown color) are macrophages based on detection of blue gran-
ules (KP1/Vector SG chromogen, blue color) in the cytoplasm. A
single antibody control (Kon 7/DAB) is shown in Figure 4. The
negative control showed very light brown staining found diffusely
throughout the tissue section. The normal renal tissue showed no
staining for either chromogen.
To exclude non-specific chromogen staining occurring by bind-
ing to unbiotinylated secondary antibody, the same specimens
were processed omitting primary antibody but applying the sec-
ondary antibody and each chromogen separately. No staining was
observed under these conditions.
To test for possible allosteric blocking of the KP1 site by the
Kon 7 antibody, the same specimens were stained with each
antibody alone and together, in reverse order (KPI followed by
Kon 7). Comparison of each condition revealed no noticeable
variation in the quantity and type of cells stained. Furthermore,
the pattern of double-labeling results was confirmed by single-
labeling for each antibody.
To compare chromogen staining intensity between the DAB
(brown) and Vector SG (blue), four of the fourteen biopsies were
single-labeled using Kon 7 and DAB or Vector SG each. DAB
stained more intensely compared to Vector SG, but each of the
chromogens maintained their respective dark brown and light
blue colors when double-labeling the same cell.
The labeled cells were found to be predominantly in patches of
infiltrating cells in the cortical and medullary interstitium and
within the glomeruli. Some specimens showed double-labeled
cells completely surrounding several proximal and distal tubules,
and occasionally within the tubular lumen.
Discussion
Our data confirm that the most significant and perhaps only
source of thromboxane in episodes of acute and chronic renal
allograft rejection are infiltrating macrophages, since only these
cells labeled for thromboxane synthase. Thromboxane synthase
expressing macrophages are also found in biopsy specimens with
histologic diagnosis of acute tubular necrosis and recurrent dis-
ease. These macrophages are found predominantly in the cortical
and medullary interstitium, but can also be found in the glomeruli
and tubules. No consistent distinction in labeling pattern or
quantity was found between biopsies with acute or chronic
rejection, which suggests that thromboxane can play an important
role in both conditions, potentially causing vasoconstriction by
affecting the peritubular and glomerular capillary beds. Further-
more, thromboxane may be a potential cause of chronic nephrop-
athy by decreasing renal perfusion and glomerular filtration rate,
leading to irreversible chronic sclerosis. The experimental tech-
nique described here confirms that thromboxane synthase ex-
pressing cells and, hence, thromboxane synthase production in
these conditions, is due to infiltrating macrophages. In addition,
based on the absence of staining in the normal renal tissue
specimens there appears to be no intrinsic thromboxane synthase
expression in the normal kidney [3].
These double-labeling studies confirm the anatomic distribu-
tion of TS positive cells we previously reported in single-labeling
studies [3]. In the previous study we used the Banif schema [7] to
describe the distribution of TS positive cells and demonstrated
that increased levels of infiltration predicted renal function im-
pairment.
In summary, we have described a simple, reproducible method
of identifying thromboxane synthase expression and specific lo-
calization of such expression using an immunohistochemical
double-labeling procedure. Thromboxane synthase may play a
broader role in renal diseases than previously expected. These
studies may provide insight into the role of infiltrating macro-
phages in the pathogenesis of acute and chronic allograft ne-
phropathy, as well as other conditions.
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